Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 11Lung Neoplasms 9Leukemia, Myeloid, Acute 9Wilms Tumor 8Osteosarcoma 8Neuroblastoma 8Neoplasm Metastasis 8Multiple Myeloma 8Glioma 8Sarcoma 7Rhabdoid Tumor 7Lymphoma, Non-Hodgkin 7Hepatoblastoma 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Rhabdomyosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Myelodysplastic Syndromes 6Medulloblastoma 6Lymphoma 6Histiocytosis, Langerhans-Cell 6Ependymoma 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Central Nervous System Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Sarcoma, Ewing 4Ovarian Neoplasms 4Melanoma 4Endometrial Neoplasms 4

Interventions

Specimen Handling 4Doxorubicin 4pembrolizumab 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Biopsy 3pazopanib 2palbociclib 2Immunoglobulin G 2Ifosfamide 2toripalimab 1talimogene laherparepvec 1silmitasertib 1selinexor 1ribociclib 1peposertib 1mirdametinib 1liposomal doxorubicin 1eribulin 1durvalumab 1cemiplimab 1abemaciclib 1X-Rays 1Vincristine 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × X-Rays × 90 days × Clear all
NCT06422806 2026-05-26

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI)

Phase 3 Recruiting
365 enrolled
Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡